ID   Karpas-707
AC   CVCL_0010
SY   KARPAS-707; Karpas 707; KARPAS 707; Karpas707
DR   NCBI_Iran; C505
DR   Wikidata; Q54899503
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1007/978-1-4613-2823-0_29;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3332852;
RX   PubMed=7079750;
RX   PubMed=10936422;
RX   PubMed=11172031;
RX   PubMed=17254797;
RX   PubMed=23074853;
WW   https://www.proteinatlas.org/learn/cellines
CC   Characteristics: Produces Ig lambda.
CC   Doubling time: 35 hours (PubMed=11172031).
CC   Omics: Deep antibody staining analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Misspelling: CARPAS 707; PubMed=17254797.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 16,18
ST   D21S11: 30,31
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 12,13
ST   FGA: 18,26
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 21
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund H., Nilsson K.;
RT   "Multiple myeloma cell lines.";
RL   (In) Human cell culture. Vol. 3. Cancer Cell Lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York (2000).
//
RX   DOI=10.1007/978-1-4613-2823-0_29;
RA   Karpas A.;
RT   "Viruses and human leukemia in vitro.";
RL   (In) Human leukemia. Cytochemical and ultrastructural techniques in diagnosis and research. Developments in Oncology, Vol. 14; Polliack A. (eds.); pp.495-526; Martinus Nijhoff Publishing; Boston (1984).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=3332852; DOI=10.1016/S0950-3536(87)80037-9;
RA   Keating A.;
RT   "Ph positive CML cell lines.";
RL   Baillieres Clin. Haematol. 1:1021-1029(1987).
//
RX   PubMed=7079750; DOI=10.1126/science.7079750;
RA   Karpas A., Fischer P., Swirsky D.;
RT   "Human myeloma cell line carrying a Philadelphia chromosome.";
RL   Science 216:997-999(1982).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//
RX   PubMed=11172031; DOI=10.1073/pnas.98.4.1799;
RA   Karpas A., Dremucheva A., Czepulkowski B.H.;
RT   "A human myeloma cell line suitable for the generation of human
RT   monoclonal antibodies.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:1799-1804(2001).
//
RX   PubMed=17254797; DOI=10.1016/j.biologicals.2006.10.001;
RA   Azari S., Ahmadi N., Tehrani M.J., Shokri F.;
RT   "Profiling and authentication of human cell lines using short tandem
RT   repeat (STR) loci: report from the National Cell Bank of Iran.";
RL   Biologicals 35:195-202(2007).
//
RX   PubMed=23074853; DOI=10.1134/S1990519X12050136;
RA   Turilova V.I., Smirnova T.D.;
RT   "Karyotypic variability of human myeloma cell lines.";
RL   Tsitologiia 54:621-636(2012).
//